I have a question: What ever happened to those "codes" Gerald talked about at the SF Conference in January which he said would increase our net present value multiple times and was the reason we wouldn't be pursuing a Lympro partner in the near future?

At that time, January 15th, 2014, we were trading at .137 cents. I haven't heard management talk about those "codes" since. At the time, it sounded like a huge deal! Does anyone know how that front is going and why it hasn't increased our net present value?

I'm waiting for an increase in shareholder value. I'm excited the company has an extra billion shares if it needs it. I'm happy Gerald is getting his compensation program worked out, he's a good guy.

Now, when will that "concrete" catalyst following the LP002 data get our pps back up to .19 or .17 or even .13 cents?

I hope very soon.